Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Menactra Needs Long-Term Safety, Efficacy Studies Post-Approval – Cmte.

Executive Summary

Sanofi-Aventis should commit to long-term efficacy and safety post-approval studies for its quadravalent meningococcal conjugate vaccine Menactra (MCV-4), an FDA advisory committee said

You may also be interested in...



Sanofi-Aventis Menactra Approved; Launch Awaits ACIP Recommendations

Sanofi-Aventis' launch of its meningococcal conjugate vaccine Menactra will await formal recommendations for use by the Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices next month

Sanofi-Aventis Menactra Approved; Launch Awaits ACIP Recommendations

Sanofi-Aventis' launch of its meningococcal conjugate vaccine Menactra will await formal recommendations for use by the Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices next month

Sanofi-Aventis Menactra Market Is $3.5 Bil. Over 10 Years, CDC Says

The potential market for Sanofi-Aventis' meningococcal conjugate vaccine Menactra is $3.5 bil. over 10 years, a Centers for Disease Control & Prevention analysis indicates

Related Content

Topics

UsernamePublicRestriction

Register

LL016789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel